/HSTM

HealthStream Inc

HSTM

$29.11USD↑+0.80%+0.23 today

MARKET CAP

851.2M

P/E (TTM)

43.4x

FWD P/E

—

DAY RANGE

$29 – $29

52W RANGE

$20

$31

AI Summary

Stalk

StalkMedium

The medium-term rally remains intact with rising EMAs and constructive higher highs/lows, but the primary pattern of Bullish Exhaustion combined with overbought readings suggests a short-term pullback risk. The long-term downtrend below the 200 DMA persists, keeping long-term bias bearish. Entries should be deferred until a pullback into the rising 9/21 EMA zone confirms support.

↑Q2 2026 revenue of $83.7M (+12.5% YoY; organic +8.3%)
↑Adjusted EBITDA reached $20.6M (+16.9% YoY), boosting margins
↓Legacy credentialing/scheduling revenue down 15% YoY to $7.4M in Q1

Full analysis →

Buying

5

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	4.08 M	111.18 M	+228.22 K	+39.4%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	635.57 K	17.24 M	+181.83 K	+80.2%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	423.00 K	11.53 M	+-54.85 K	+16.5%	0.02%
AC Aqr Capital Management LLC Q2 2026	BUY	240.23 K	6.55 M	+181.39 K	+437.2%	0.00%
MG Man Group Plc Q2 2026	BUY	142.91 K	3.89 M	+132.01 K	+1626.4%	0.01%
MM Millennium Management LLC Q2 2026	SELL	121.34 K	3.31 M	+-54.29 K	-9.1%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	21.89 K	453.82 K	+10.95 K	+79.8%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	10.38 K	282.94 K	+-68.38 K	-82.7%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-15.03 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-12.72 K	-100.0%	0.00%